Correlation Between Chevron Corp and Prelude Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chevron Corp and Prelude Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chevron Corp and Prelude Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chevron Corp and Prelude Therapeutics, you can compare the effects of market volatilities on Chevron Corp and Prelude Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chevron Corp with a short position of Prelude Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chevron Corp and Prelude Therapeutics.

Diversification Opportunities for Chevron Corp and Prelude Therapeutics

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Chevron and Prelude is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Chevron Corp and Prelude Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prelude Therapeutics and Chevron Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chevron Corp are associated (or correlated) with Prelude Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prelude Therapeutics has no effect on the direction of Chevron Corp i.e., Chevron Corp and Prelude Therapeutics go up and down completely randomly.

Pair Corralation between Chevron Corp and Prelude Therapeutics

Considering the 90-day investment horizon Chevron Corp is expected to generate 0.16 times more return on investment than Prelude Therapeutics. However, Chevron Corp is 6.35 times less risky than Prelude Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Prelude Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  15,414  in Chevron Corp on August 31, 2024 and sell it today you would earn a total of  779.00  from holding Chevron Corp or generate 5.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Chevron Corp  vs.  Prelude Therapeutics

 Performance 
       Timeline  
Chevron Corp 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Chevron Corp are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly sluggish basic indicators, Chevron Corp may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Prelude Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prelude Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Chevron Corp and Prelude Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chevron Corp and Prelude Therapeutics

The main advantage of trading using opposite Chevron Corp and Prelude Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chevron Corp position performs unexpectedly, Prelude Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prelude Therapeutics will offset losses from the drop in Prelude Therapeutics' long position.
The idea behind Chevron Corp and Prelude Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas